Evidence map›Paper›PMID 35311423›Full record

ArticleAnnals of medicine2022

'I need time to start antiretroviral therapy': understanding reasons for delayed ART initiation among people diagnosed with HIV in Lusaka, Zambia'.

Chanda Mwamba, Laura K Beres, Stephanie M Topp, Njekwa Mukamba, Sandra Simbeza, Kombatende Sikombe, Aaloke Mody, Elvin Geng, Charles B Holmes, Caitlin E Kennedy and 3 more

Abstract read
In one paragraph

Article in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chanda MwambaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-7626-6273
Laura K BeresDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-4731-7828
Stephanie M ToppCollege of Public Health, Medical & Veterinary Sciences, James Cook University, Townsville, Australia.ORCID 0000-0002-3448-7983
Njekwa MukambaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-5757-6858
Sandra SimbezaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-0150-3369
Kombatende SikombeCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-8187-8661
Aaloke ModyWashington University School of Medicine in St. Louis, MO, USA.ORCID 0000-0003-3787-365X
Elvin GengWashington University School of Medicine in St. Louis, MO, USA.ORCID 0000-0002-0825-1424
Charles B HolmesGeorgetown University, Washington, DC, USA.ORCID 0000-0002-7924-6761
Caitlin E KennedyDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0001-6820-063X
Izukanji SikazweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-3898-2607
Julie A DenisonDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-4670-093X
Carolyn Bolton MooreCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0001-9103-7746

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Patterns and Factors Influencing Return to Care among HIV Patients in ZambiaF31MH109378 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BERES, LAURA · 2016 to 2019
$157k
NIAID NIH HHS P30 AI094189NIMH NIH HHS F31 MH109378
6 · The paper itself

Abstract

introductionRapid antiretroviral therapy (ART) initiation can improve patient outcomes such as viral suppression and prevent new infections. However, not everyone who can start ART does so immediately.

methodsWe conducted a qualitative study to inform interventions supporting rapid initiation in the 'Test and Start' era. We purposively sampled 20 adult patients living with HIV and a previous gap in care from ten health facilities in Lusaka, Zambia for interviews. We inductively analysed transcripts using a thematic, narrative approach. In their narratives, seven participants discussed delaying ART initiation.

resultsDrawing on messages gleaned from facility-based counselling and community information, many cited greater fear of rapid sickness or death due to imperfect adherence or treatment side effects than negative health consequences due to delayed initiation. Participants described needing time to 'prepare' their minds for a lifetime treatment commitment. Concerns about inadvertent HIV status disclosure during drug collection discouraged immediate initiation, as did feeling healthy, and worries about the impact of ART initiation on relationship dynamics.

conclusionFindings suggest that counselling messages should accurately communicate treatment risks, without perpetuating fear-based narratives about HIV. Identifying and managing patient-specific concerns and reasons for the 'need for time' may be important for supporting individuals to rapidly accept lifelong treatment.Key messagesFear-based adherence messaging in health facilities about the dangers of missing a treatment dose or changing the time when ART is taken contributes to Zambian patients' refusals of immediate ART initiationResponsive health systems that balance a stated need for time to accept one's diagnosis and prepare to embark on a lifelong treatment plan with interventions to identify and manage patient-specific treatment related fears and concerns may support more rapid ART initiationPerceived social stigma around HIV continues to be a significant challenge for treatment initiation.

Indexed as

Anti-HIV AgentsHIV InfectionsAdultCounselingHumansQualitative ResearchZambiaAnti-HIV Agentsantiretroviral refusalART initiationdelayed treatmenttest and startZambia

Identifiers

PMID35311423
PMCPMC8942536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.